Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,932Revenue (TTM) $M170Net Margin (%)-58.6Altman Z-Score0.9
Enterprise Value $M1,846EPS (TTM) $-0.7Operating Margin %-50.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-58.6Higher ROA y-yN
Price/Book37.110-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsY
Price/Sales10.15-y EBITDA Growth Rate %--Current Ratio4.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-1,857.6ROA % (ttm)-49.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M169ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARRY is held by these investors:



ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Redmile Group, LLC10% Owner 2016-09-28Sell2,492,578$6.3666.04view
Redmile Group, LLC10% Owner 2016-09-15Sell400,000$3.5201.71view
Redmile Group, LLC10% Owner 2016-09-15Buy400,000$3.51200.85view
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.19231.03view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.6193.33view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67187.74view
Redmile Group, LLC10% Owner 2015-10-01Buy782,592$4.58130.57view
Redmile Group, LLC10% Owner 2015-10-01Buy600,140$4.58130.57view
Redmile Group, LLC10% Owner 2015-08-26Buy49,900$5.4892.7view
Redmile Group, LLC10% Owner 2015-08-25Buy790,000$5.3896.28view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Screen: Stocks With Estimated Revenue Up 5% - January Jan 18 2016 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 

More From Other Websites
Biotech Industry Positioned for a Potential Breakout in 2017: Today's Reports on Array Biopharma and... Feb 17 2017
ETFs with exposure to Array BioPharma, Inc. : February 14, 2017 Feb 14 2017
ARRAY BIOPHARMA INC Financials Feb 14 2017
Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017 Feb 13 2017
Edited Transcript of ARRY earnings conference call or presentation 9-Feb-17 2:00pm GMT Feb 09 2017
Array BioPharma 4Q Loss 14c/Share Beats Street Feb 09 2017
Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today Feb 09 2017
Array BioPharma reports 2Q loss Feb 09 2017
Array BioPharma reports 2Q loss Feb 09 2017
ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 09 2017
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017 Feb 09 2017
ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report Feb 09 2017
Q2 2017 Array Biopharma Inc Earnings Release - Before Market Open Feb 09 2017
Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference Feb 08 2017
Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More Feb 03 2017
Array Biopharma downgraded by JP Morgan Feb 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)